Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2021 Sep 24;228:109067. doi: 10.1016/j.drugalcdep.2021.109067

Table 1.

Participant Characteristics (N=1,464)

Variable N (%a)
Ageb 49.6 (14.8)
Femalec 911 (62.2)
Not Hispanic/Latinx 1447 (98.8)
White 1361 (93.0)
Marital status
 Married 797 (54.5)
 Divorced 244 (16.7)
 Widowed 72 (4.9)
 Separated 53 (3.6)
 Never married 213 (14.6)
 Member unmarried couple 77 (5.3)
Employment
 Full-time 515 (35.2)
 Part-time 79 (5.4)
 Temp leave 72 (4.92)
 Looking for work 45 (3.1)
 Retired 208 (14.2)
 Disabled 329 (22.5)
 Homemaker 64 (4.4)
 Student 16 (1.1)
Insured 1380 (94.3)
Overdose Experiences, Self and Witnessed—Drug instrument
 No lifetime overdose 1318 (90.0)
 1 overdose 56 (3.8)
 2 overdoses 42 (2.9)
 3 overdoses 13 (0.9)
 4 overdoses 4 (0.3)
 5 overdoses 8 (0.6)
 6 + overdoses 17 (1.2)
Short Form12 general health
 Poor 148 (10.1)
 Fair 447 (30.5)
 Good 565 (38.6)
 Very good 246 (16.8)
 Excellent 54 (3.7)
Patient Health Questionnaire 2 (depression) 286 (19.9)
Brief Pain Inventory
 Pain severityb 4.85(2.2)
 Pain interferenceb 4.84(2.8)
Alcohol, Smoking, and Substance Involvement Screening Test
Prescription opioids
 Low 772 (54.1)
 Moderate 623 (43.6)
 High 33 (2.3)
Street opioids
 Low 1430 (98.7)
 Moderate 13 (0.9)
 High 6 (0.4)
Cannabis
 Low 1274 (88.5)
 Moderate 158 (10.9)
 High 8 (0.6)
Sedatives
 Low 1199 (82.9)
 Moderate 238 (16.5)
 High 10 (0.7)
Cocaine
 Low 1417 (97.9)
 Moderate 30 (2.1)
 High 1 (0.1)
Tobacco
 Low 894 (62.3)
 Moderate 495 (34.5)
 High 45 (3.1)
Alcohol
 Low 1300 (90.5)
 Moderate 115 (8.0)
 High 21 (1.5)
Methamphetamine
 Low 1426 (98.5)
 Moderate 18 (1.2)
 High 3 (0.2)
Hallucinogensd
 Low 1428 (99.4)
 Moderate 9 (0.6)
Prescription stimulantsd
 Low 1387 (95.7)
 Moderate 62 (4.3)
Inhalantsc
 Low 1453 (99.9)
 Moderate 2 (0.1)
a

Categories may not total 1,464 due to “prefer not to answer” responses.

b

Mean (SD) used in place of N (%).

c

“none of these describe me” analyzed as male due to limited sample size of subgroup (n=1).

d

No high-risk use was reported.